Generic medicines face no tariffs, though the Trump administration reserves the right to revisit that in the future. Some ...

The nursing workforce crisis has improved slightly since the pandemic, but it’s far from over. New research from the National Council of State Boards of Nursing (NCSBN) shows that nurses are still ...

Northern California-based Sutter Health is acquiring Minnesota-based Allina Health, the two systems announced this week. The deal would create a nonprofit health system spanning three states — ...

Salt Lake City, Utah-based Intermountain Healthcare has opened a virtual hospital called Connect Care Pro, which brings together the system's 35 telehealth programs and over 500 providers and ...

Intermountain Health, the largest nonprofit healthcare provider in the Intermountain West region, struck a multi-year collaboration with a young generative AI startup this month. The health system is ...

When Kaiser Permanente CEO Greg Adams thinks about the tall task of advancing value-based care throughout the country, he harkens back to an idea often mentioned by his organization’s founder — Henry ...

Mallinckrodt and Endo, pharmaceutical companies that have each encountered business struggles, announced Thursday a $6.7 billion merger that they contend will result in a combined entity with the ...

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to exploring the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Barbara Levy, chief medical ...

The Department of Justice filed an antitrust lawsuit against NewYork-Presbyterian, alleging the hospital used “all-or-nothing” contracts that blocked lower-cost plans and limited competition. The case ...

Private equity ownership of healthcare facilities has led to significant problems — including hospital closures, reduced staffing and compromised healthcare services — showing the need for regulation, ...

When the CEOs of UnitedHealth, CVS, Cigna, and Elevance appeared before Congress, they weren’t just summoned to account for high premiums, hidden prices, and claim denials. They were expected to ...

Bristol Myers Squibb hasn’t had much luck with its efforts to develop cancer treatments called T cell engagers. But the pharmaceutical company isn’t done pursuing this type of targeted cancer therapy, ...